Morales-González G, Pichardo-Bahena R

Idioma: Español
Referencias bibliográficas: 31
Paginas: 4-17
Archivo PDF: 162.08 Kb.

RESUMEN

La primera causa de hiperparatiroidismo primario, observada en el 80% de los casos debido a la presencia de un adenoma y en menor proporción a hiperplasia o a paratiromatosis. Esta entidad tiene manifestaciones clínicas variadas, con una afección multiorgánica con una compleja fisiopatología. Las características clínicas así como histopatológicas son revisadas en este artículo.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Viera AJ. Hyperparathyroidism. Clin Fam Pract 2002; 4 627-

2. DeLellis RA. Hyperparathyroidism. Atlas of tumor pathology, tumors of the parathyroid gland. DeLellis RA, Rosai J., Sobi LH, eds. Washington DC. Armed Forces Institute, 1993: 16-24.

3. Guyton A. Hormona paratiroidea, calcitonina, metabolismo del calcio y del fosfato, vitamina D, huesos y dientes. Guyton, AC. Hall, JE eds. Tratado de Fisiológica Médica. México. McGraw-Hill Interamericana; 2001: 1081-1100.

4. Agregar referencia de libro de histología

5. Holick MF, Krane SM, Potts JT. Calcium, phosphorus and bone metabolism: Calcium-regulating hormones. Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL eds. Principles of Internal Medicine. Nueva York. McGraw-Hill; 1998: 2214-2247.

6. Eigelberger MS, Orlo HC. Surgical approaches to primary hyperparathyroidism. Endocrinol Metab Clin North Am 2000; 29: 479-502.

7. Silverberg S. Natural history of primary hyperparathyroidism. Endocrinol and Metab Clin North Am 2000; 29: 451-464.

8. Kearns AE, Thompson GB. Medical and surgical management of hyperparathyroidism. Mayo Clinic Proceedings 2002; 77: 87-91.

9. Miller FR, Netterville JL. Surgical management of thyroid and parathyroid disorders. Med Clin North Am 1999; 83 247-259.

10. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000; 343 1863-1875.

11. Gimm O, Niederle BE, Weber T, Bockhorn M, Ukkat J, Brauckhoff, M, Thanh PN, Frilling A, Klar E, Niederle B, Dralle H. RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome? Surgery 2002; 132: 952-9.

12. Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, Skarulis MC, Spiegel AM, Libutti SK, Alexander HR Jr, Chen CC, Chang R, Chandrasekharappa SC, Collins FS. Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res 2002; Suppl 2: N37-43.

13. Ghandur-Mnaymneh L, Kimura N. The parathyroid adenoma. Am J Pathol 1984; 115: 70-83.

14. Apel RL, Asa SL. The parathyroid gland. Endrocrine pathology. Livolsi VA, Asa SL, eds. Philadelphia. Churchill Livingstone, 2002: 103-147.

15. Brown EM. The pathophysiology of primary hyperparathyroidism. J Bone Miner Res 2002; Suppl 2: N24-9.

16. Schacahter PP, Ayesh S, Schneider T, Laster M, Czerniak A, Hochberg A. Expression of Kinase genes in primary hyperparathyroidim: adenoma versus hyperplastic parathyroid tissue. Surgery 2002; 132: 1094-1099.

17. Silverberg SJ, Bilezikian JP, Bone HG, Talpos GB, Horwitz MJ, Stewart AF. Therapeutic controversy: Therapeutic controversies in primary hyperparathyroidism. JClin Endocrinol Metab 1999; 84: 2275-2285.

18. Bilezikian J. Primary hyperparathyroidism: When to observe and when to operate. Endocrinol Metab Clin North Am 2000; 29: 465-478.

19. Prager G, Kalaschek A, Kaczirek K, Passler K, Scheuba C, Sonneck G, Niederle B. Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery 2002; 132: 930-6.

20. Gaurav A, Saroj KM, Dilip KK, Anil SJ, Vivek A, Sushil KG, Ambrish M. Recovery pattern of patients with osteitis fibrosa cystica in primary hyperparathyroidism after successful parathyroidectomy. Surgery 2002; 132: 1075-1085.

21. Almqvist EG, Bondeson AG, Bondeson L, Nissborg A, Smedgard P, Svensson SE. Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery 2002; 132: 1126-1132.

22. Roche NA, Young AE. Role surgery in mild primary hyperparathyroidism in the elderly. BMJ 2000; 87: 1640-1649.

23. Strewler GJ. Medical approaches to primary hyperparathyroidism. Endocrinol Metab Clin North Am 2000; 29: 523-539.

24. Jones JJ, Brunaud L, Dowd CF, Duh Q-Y, Morit E, Clark OH. Accuracy of selective venous sampling for intact parathyroid hormon in difficult patients with recurrent or persistent hyperparathyroidism. Surgery 2002; 132: 944-951.

25. Elaraj DM, Remaley AT, Simonds WF, Skarulis MC, Libutti SK, Bartlett DL, Venzon DJ, Marx SJ, Alexander HR. Utility of rapid intraoperative parathyroid hormone assay to predict severe postoperative hypocalcemia after reoperation for hyperparathyroidism. Surgery 2002; 132: 1028-34.

26. Sywak MS, Knowlton ST, Pasieka JL, Parsons LL, Jones J. Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery 2002; 132: 1013-20.

27. Heath DA. Localization of parathyroid tumours. Clin Endocrinol (Oxf) 1995; 43: 523-52.

28. Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet 1980; 1: 1317-1320.

29. Utiger RD. Treatment of primary hyperparathyroidism. N Engl J Med 1999; 341: 1301-1302.

30. Silverberg SJ, Shane E, Jacobs T. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999; 341: 1249-1255.

31. Royal RE, Delpassand ES, Shapiro SE, Fritsche HA, Vassilopoulou-Sellin R, Sherman SI, Gagel RF, Evans DD, Lee JE. Improving the yiel of preoperative parathyroid localization: technetium Tc-99m-sestamibi imaging after thyroid suppression. Surgery 2002; 132: 968-975.